Health Science Report
Site Navigation



Research that helps:



Home

  >

Herpes

>

Genital Herpes Hsv2

>

Genital Herpes Vaccine

Genital Herpes Vaccine

A genital herpes vaccine is not avialable yet, so many people get infected with genital herpes, HPV and other genital disorders; a cone biopsy is used only in severe cases of HPV. Isoprinosine, pending FDA approval, for antiviral action, and ability to stimulate the body's immune response has promise. 3-5 years is projected before vaccination becomes available. Avoiding creation of immune resistant strains while inoculating with nonspecific vaccines or overcoming the body with antiviral toxins is complex. A genital herpes vaccine is not avialable yet, so many people get infected with genital herpes, HPV and other genital disorders; a cone biopsy is used only in severe cases of HPV.

Just select from the Research Topics on the adjacent gray column for easy viewing of important articles. If this is your first visit, click here for a brief summary of this website.

.

Genital Herpes Vaccine

  -  

Genital Herpes, Cone Biopsy

HSV immunization developments has its challenges; both viruses share common genetic base yielding related expressed type-common surface antigens providing a level of antibody cross protection. A genital herpes vaccine is not avialable yet, so many people get infected with genital herpes, HPV and other genital disorders; a cone biopsy is used only in severe cases of HPV.

Other Topics: HPV, HPV Disease, HPV Virus, HPV Photo, HPV Image, Human Papillomavirus, Human Papilloma Virus and Pregnancy, Biopsy Cervical Dysplasia, Irregular Pap Smear, Genital Wart Pic

Dr. Joe Glickman, Jr., M.D.

BBBOnLine Reliability Seal

Copyright © 1996-2009 by Health Science Report™ for the following: